Cargando…
Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus
APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses and were shown to suppress hepatitis B virus (HBV) replication by deaminating and destroying the major form of HBV genome, covalently closed circular DNA (cccDNA), without toxicity to the infected cells....
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176074/ https://www.ncbi.nlm.nih.gov/pubmed/37187708 http://dx.doi.org/10.1016/j.omtn.2023.04.016 |
_version_ | 1785040356042080256 |
---|---|
author | Kostyushev, Dmitry Brezgin, Sergey Kostyusheva, Anastasiya Ponomareva, Natalia Bayurova, Ekaterina Zakirova, Natalia Kondrashova, Alla Goptar, Irina Nikiforova, Anastasiya Sudina, Anna Babin, Yurii Gordeychuk, Ilya Lukashev, Alexander Zamyatnin, Andrey A. Ivanov, Alexander Chulanov, Vladimir |
author_facet | Kostyushev, Dmitry Brezgin, Sergey Kostyusheva, Anastasiya Ponomareva, Natalia Bayurova, Ekaterina Zakirova, Natalia Kondrashova, Alla Goptar, Irina Nikiforova, Anastasiya Sudina, Anna Babin, Yurii Gordeychuk, Ilya Lukashev, Alexander Zamyatnin, Andrey A. Ivanov, Alexander Chulanov, Vladimir |
author_sort | Kostyushev, Dmitry |
collection | PubMed |
description | APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses and were shown to suppress hepatitis B virus (HBV) replication by deaminating and destroying the major form of HBV genome, covalently closed circular DNA (cccDNA), without toxicity to the infected cells. However, developing anti-HBV therapeutics based on APOBEC/AID is complicated by the lack of tools for activating and controlling their expression. Here, we developed a CRISPR-activation-based approach (CRISPRa) to induce APOBEC/AID transient overexpression (>4–800,000-fold increase in mRNA levels). Using this new strategy, we were able to control APOBEC/AID expression and monitor their effects on HBV replication, mutation, and cellular toxicity. CRISPRa prominently reduced HBV replication (∼90%–99% decline of viral intermediates), deaminated and destroyed cccDNA, but induced mutagenesis in cancer-related genes. By coupling CRISPRa with attenuated sgRNA technology, we demonstrate that APOBEC/AID activation can be precisely controlled, eliminating off-site mutagenesis in virus-containing cells while preserving prominent antiviral activity. This study untangles the differences in the effects of physiologically expressed APOBEC/AID on HBV replication and cellular genome, provides insights into the molecular mechanisms of HBV cccDNA mutagenesis, repair, and degradation, and, finally, presents a strategy for a tunable control of APOBEC/AID expression and for suppressing HBV replication without toxicity. |
format | Online Article Text |
id | pubmed-10176074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-101760742023-05-13 Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus Kostyushev, Dmitry Brezgin, Sergey Kostyusheva, Anastasiya Ponomareva, Natalia Bayurova, Ekaterina Zakirova, Natalia Kondrashova, Alla Goptar, Irina Nikiforova, Anastasiya Sudina, Anna Babin, Yurii Gordeychuk, Ilya Lukashev, Alexander Zamyatnin, Andrey A. Ivanov, Alexander Chulanov, Vladimir Mol Ther Nucleic Acids Original Article APOBEC/AID cytidine deaminases play an important role in innate immunity and antiviral defenses and were shown to suppress hepatitis B virus (HBV) replication by deaminating and destroying the major form of HBV genome, covalently closed circular DNA (cccDNA), without toxicity to the infected cells. However, developing anti-HBV therapeutics based on APOBEC/AID is complicated by the lack of tools for activating and controlling their expression. Here, we developed a CRISPR-activation-based approach (CRISPRa) to induce APOBEC/AID transient overexpression (>4–800,000-fold increase in mRNA levels). Using this new strategy, we were able to control APOBEC/AID expression and monitor their effects on HBV replication, mutation, and cellular toxicity. CRISPRa prominently reduced HBV replication (∼90%–99% decline of viral intermediates), deaminated and destroyed cccDNA, but induced mutagenesis in cancer-related genes. By coupling CRISPRa with attenuated sgRNA technology, we demonstrate that APOBEC/AID activation can be precisely controlled, eliminating off-site mutagenesis in virus-containing cells while preserving prominent antiviral activity. This study untangles the differences in the effects of physiologically expressed APOBEC/AID on HBV replication and cellular genome, provides insights into the molecular mechanisms of HBV cccDNA mutagenesis, repair, and degradation, and, finally, presents a strategy for a tunable control of APOBEC/AID expression and for suppressing HBV replication without toxicity. American Society of Gene & Cell Therapy 2023-04-20 /pmc/articles/PMC10176074/ /pubmed/37187708 http://dx.doi.org/10.1016/j.omtn.2023.04.016 Text en Crown Copyright © 2023. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Kostyushev, Dmitry Brezgin, Sergey Kostyusheva, Anastasiya Ponomareva, Natalia Bayurova, Ekaterina Zakirova, Natalia Kondrashova, Alla Goptar, Irina Nikiforova, Anastasiya Sudina, Anna Babin, Yurii Gordeychuk, Ilya Lukashev, Alexander Zamyatnin, Andrey A. Ivanov, Alexander Chulanov, Vladimir Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title | Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title_full | Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title_fullStr | Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title_full_unstemmed | Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title_short | Transient and tunable CRISPRa regulation of APOBEC/AID genes for targeting hepatitis B virus |
title_sort | transient and tunable crispra regulation of apobec/aid genes for targeting hepatitis b virus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176074/ https://www.ncbi.nlm.nih.gov/pubmed/37187708 http://dx.doi.org/10.1016/j.omtn.2023.04.016 |
work_keys_str_mv | AT kostyushevdmitry transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT brezginsergey transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT kostyushevaanastasiya transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT ponomarevanatalia transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT bayurovaekaterina transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT zakirovanatalia transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT kondrashovaalla transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT goptaririna transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT nikiforovaanastasiya transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT sudinaanna transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT babinyurii transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT gordeychukilya transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT lukashevalexander transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT zamyatninandreya transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT ivanovalexander transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus AT chulanovvladimir transientandtunablecrispraregulationofapobecaidgenesfortargetinghepatitisbvirus |